THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

William Berry to Prostatic Neoplasms, Castration-Resistant

Back to Details
This is a "connection" page, showing publications William Berry has written about Prostatic Neoplasms, Castration-Resistant.
William Berry
Connection Strength
0.401
Prostatic Neoplasms, Castration-Resistant
  1. Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-na?ve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D. Eur Urol Oncol. 2025 Jun; 8(3):641-651.
    View in: PubMed
    Score: 0.222
  2. A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer. Cancer. 2021 08 15; 127(16):2954-2965.
    View in: PubMed
    Score: 0.179
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES